查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
免疫譜庫測序市場：按產品類型,按應用,按國家,按地區-行業分析,市場規模,市場份額,2023-2030 年預測
市場調查報告書
商品編碼
1290857

免疫譜庫測序市場：按產品類型,按應用,按國家,按地區-行業分析,市場規模,市場份額,2023-2030 年預測

Immune Repertoire Sequencing Market with COVID-19 Impact Analysis, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 387 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年免疫譜庫測序市場規模將達到13.158億美元，2023年至2030年復合年增長率為7.7%

免疫庫測序市場 - 市場動態

政府加大對基於藥物基因組學的藥物召回的支持預計將推動市場需求

免疫組庫測序可以通過提供對患者免疫系統和對藥物治療的反應的額外了解來促進藥物基因組學。例如，在癌症治療方面，免疫組庫測序有助於識別免疫系統識別的腫瘤特異性抗原。然而，針對癌症和其他傳染病的免疫療法的需求不斷增加預計將推動免疫庫測序市場的增長。免疫治療藥物在某些癌症中比其他癌症效果更好，對某些患者來說可能是一個奇蹟，但並非對所有人來說都是奇蹟。總體回復率約為15-20%。此外，根據約翰霍普金斯醫學的數據，癌症免疫治療有自己的股票指數，由25家價值超過1億美元的公司組成。

免疫組庫測序市場 - 關鍵見解

  • 由於可持續增長意識的增強，免疫庫測序行業預計將大幅增長
  • 按產品類型劃分，檢測試劑盒預計將在 2022 年佔據最大的市場份額
  • 從應用來看，癌症免疫治療是2022年的主要類型。
  • 按地區劃分，北美是2022年的主要收入來源。

免疫組庫測序市場細分分析：

全球免疫組庫測序市場根據產品類型,應用,技術和地區進行細分。

根據產品類型，市場分為三類：儀器和檢測試劑盒。檢測試劑盒可能會主導市場。這些試劑盒通常包括用於樣品製備,文庫構建,測序和數據分析的試劑和方案。

市場按應用分為六類：癌症免疫治療,生物標誌物發現,自身免疫性疾病,疫苗開發和功效,移植排斥和耐受,傳染病和其他。癌症免疫療法在市場上佔據主導地位，並將在預測期內保持其主導地位。癌症免疫療法是一個快速發展的領域，利用人體的免疫系統來對抗癌症。

免疫庫測序市場 - 地理洞察

從地域上看，該市場遍布北美,拉丁美洲,歐洲,亞太,中東和非洲地區。這些地區根據引入業務的國家進一步劃分。由於政府為改善醫療基礎設施提供的資金不斷增加，預計北美將主導免疫組庫測序市場的增長。在醫療健康研發方面，聯邦政府投資占美國所有醫療健康研發的四分之一（25%），為615億美元，僅美國國立衛生研究院（NIH）就佔這一數字，2020年將佔20佔所有此類投資的%（489 億美元）。在這個層面上，美國國立衛生研究院是僅次於生物製藥行業的第二大醫療健康研究資助者。然而，增加政府資助可以為研究人員和機構提供資源來開展免疫組庫測序研究。由於研發和新產品發布的增加，歐洲和亞太地區預計在預測期內將大幅增長。

免疫譜庫測序市場-競爭格局：

對免疫組庫測序的需求正在穩步增長，因為它在闡明免疫系統,疾病進展和開發個性化療法方面發揮著關鍵作用。每家公司都提供用於免疫譜分析的測序儀器,試劑和軟件解決方案。免疫組庫測序市場競爭激烈，各個公司和研究機構都在推動創新並提供免疫組庫測序和分析的解決方案。測序技術,生物信息學工具和數據分析方法的進步繼續塑造競爭格局並促進市場的增長。例如，Thermofisher宣布，將於 2023 年推出新的 Ion Torrent Oncomine 免疫組庫檢測系列，旨在檢測在免疫反應系統中發揮關鍵作用的 T 細胞和 B 細胞的潛在惡性克隆。

近期動向

Pfizer和Adaptive Biotechnologies Corporation啟動了一項轉化研究合作，利用適應性免疫系統的下一代測序來推進輝瑞不斷增長的免疫腫瘤學特許經營權。根據協議，Pfizer和 Adaptive 尋求將藥物開發和平台技術方面的生物標誌物專業知識結合起來，以確定可能優先受益於免疫治療的患者。

研究的主要特點

  • 本研究報告以2022年為基準年，提供了免疫譜庫測序市場的市場規模,複合年增長率（CAGR%）,估計和預測（2023-2030年）。
  • 該研究報告為客戶提供了免疫譜庫測序市場的最新趨勢見解。
  • 該研究報告闡明了不同細分市場/國家的潛在增長機會，並說明了免疫譜庫測序市場有吸引力的投資主張矩陣。
  • 總體報告確定了新的投資機會,現有企業面臨的挑戰以及免疫組庫測序市場可持續發展的增長動力。
  • COVID-19 對免疫譜庫測序市場規模,預測,複合年增長率和市場動態的影響將在研究範圍下詳細討論。它還涵蓋了對新冠疫情後免疫庫測序市場的深入見解。
  • 為了向本報告的用戶提供免疫組庫測序市場的全面了解，還包括免疫組庫測序市場的競爭格局和關鍵創新者分析。
  • 該研究涵蓋了基於市場規模,增長率和吸引力對所有行業領域進行基準測試的增長前景映射分析。
  • 它提供了主要市場進入者的詳細公司簡介，以幫助您了解免疫譜庫測序市場中運營公司的財務信息和戰略舉措。
  • 此外，報告還揭示了全球和區域市場主要進入者的重大收購和兼併,聯盟和合資企業,新產品推出,研發和區域擴張。
  • 免疫譜庫測序全球市場報告主要面向該行業的各個利益相關者，如供應商,投資者,新進入者,分銷商和財務分析師。

目錄

第一章 免疫組庫測序市場概述

  • 調查範圍

第二章執行摘要

  • 市場細分
  • 競爭考慮

第 3 章 免疫譜測序的主要市場趨勢

  • 免疫組庫測序的市場驅動因素
  • 免疫組庫測序市場製約因素
  • 免疫組庫測序的市場機會
  • 免疫組庫測序市場未來趨勢

第四章 免疫庫測序行業概況

  • PEST分析
  • 波特五力分析
  • 繪製增長前景
  • 監管框架分析

第五章免疫庫測序市場：COVID-19疾病的影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後的影響分析

第六章 免疫組庫測序市場格局

  • 2022 年免疫譜庫測序市場份額分析
  • 主要製造商的細分數據
    • 已成立公司分析
    • 啟動分析

7 免疫譜庫測序市場-按產品類型

  • 概述
    • 按產品類型劃分的細分市場份額分析
    • 機器
    • 檢測試劑盒

8 免疫譜庫測序市場——按應用分類

  • 概述
    • 按應用劃分的細分市場份額分析
    • 癌症免疫治療
    • 生物標誌物發現
    • 自身免疫性疾病
    • 疫苗開發和功效
    • 移植排斥和耐受
    • 感染
    • 其他

9 免疫譜庫測序市場-按地區

  • 介紹
  • 北美
    • 概述
    • 北美領先的免疫組庫測序製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲領先的免疫組庫測序製造商
    • 德國
    • 意大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 其他
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區領先的免疫組庫測序製造商
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳大利亞
    • 泰國
    • 印度尼西亞
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲領先的免疫組庫測序製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概述
    • 中東和非洲領先的免疫組庫測序製造商
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第十章 免疫組庫測序行業重點廠商分析

  • 比賽儀表板
  • 公司簡介
    • Illumina Inc.
    • Thermo Fisher Scientific
    • PacBio
    • CD Genomics
    • Agilent Technologies, Inc
    • F. Hoffmann-La Roche Ltd
    • BGI Group Guangdong
    • Takara Bio, Inc.
    • Adaptive Biotechnologies
    • Juno Therapeutics
    • Atreca, Inc.
    • irepertoire, Inc.

第十一章 分析師的全面看法

Product Code: ANV1311

REPORT HIGHLIGHT

Immune Repertoire Sequencing Market size was valued at USD 1,315.8 million in 2022, expanding at a CAGR of 7.7% from 2023 to 2030.

Immune repertoire sequencing is a technique used to analyze the diversity and composition of the immune system's repertoire of antibodies or T cell receptors. Immune repertoire refers to all of the unique T-cell receptor and B-cell receptor genetic rearrangements within the adaptive immune system It has unique advantages compared to the more common diagnostic and prognostic techniques that predate it. The traditional strategies for studying the immune repertoire, which include spectating, Sanger sequencing et al., are laborious, costly, and insufficient for generating a high-resolution picture of the immune repertoire. For instance, specific disease prognoses can lead to the evolution of similar or identical CDR3s in different patients. CDR3 sequencing can thus potentially be used for diagnosis.

Immune Repertoire Sequencing Market- Market Dynamics

An increase in government support for pharmacogenomics-based drug recovery is expected to propel market demand

Immune repertoire sequencing can accessory pharmacogenomics by providing additional acumens into a patient's immune system and its response to drug therapies. For example, in the perspective of cancer treatment, immune repertoire sequencing can help identify tumor-specific antigens recognized by the immune system. However, the increase in demand for immunotherapy for cancer and other infectious diseases is expected to propel the growth of the Immune Repertoire Sequencing Market. Immunotherapy drugs work better in some cancers than others and while they can be a miracle for some, they fail to work for all patients. Overall response rates are about 15 to 20%. And also there is so much pharmaceutical R&D that cancer immunotherapy has its own stock index of 25 companies worth USD100 million or more, according to Johns Hopkins Medicine.

Immune Repertoire Sequencing Market- Key Insights

  • As per the analysis shared by our research analyst, the global Immune Repertoire Sequencing market is estimated to grow annually at a CAGR of around XX% over the forecast period (2023-2030)
  • The Immune Repertoire Sequencing industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on product type segmentation, Assay Kits was predicted to show maximum market share in the year 2022
  • Based on Application segmentation, Cancer Immunotherapy was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Immune Repertoire Sequencing Market- Segmentation Analysis:

The Global Immune Repertoire Sequencing Market is segmented on the basis of Product Type, Application, Technology, and Region.

The market is divided into three categories based on product type: Instruments and Assay Kits. Assay Kits are likely to dominate the market. These kits typically include reagents and protocols for sample preparation, library construction, sequencing, and data analysis.

The market is divided into six categories based on application: Cancer Immunotherapy, Biomarker Discovery, Autoimmune Diseases, Vaccine Development and Efficacy, Transplant Rejection, and Tolerance, Infectious Diseases, and Others. Cancer Immunotherapy dominates the market and is likely to maintain its dominance during the forecast period. Cancer immunotherapy is a rapidly advancing field that utilizes the body's immune system to fight cancer.

Immune Repertoire Sequencing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Immune Repertoire Sequencing Market, due to rising Government Funding to Improve the Healthcare Infrastructure. Medical and Health Research and Development predicted that the Federal government investment accounts for one-quarter (25%) of all U.S. medical and health R&D at USD61.5 billion, with the National Institutes of Health (NIH) alone accounting for 20% (USD48.9 billion) of all such investment in 2020. At this level, NIH is the second largest funder of medical and health research after the biopharmaceutical industry. However, Increased government funding can provide researchers and institutions with more resources to conduct research on immune repertoire sequencing. Europe and the Asia Pacific are expected to expand significant growth during the forecast period, due to increasing research and development and launches of novel products.

Immune Repertoire Sequencing Market- Competitive Landscape:

The demand for immune repertoire sequencing has been steadily increasing due to its vital role in understanding the immune system, disease progression, and developing personalized therapies. The companies provide sequencing instruments, reagents, and software solutions for immune repertoire analysis. The immune repertoire sequencing market is competitive, with a range of companies and research institutions driving innovation and providing solutions for sequencing and analyzing immune repertoires. Advancements in sequencing technologies, bioinformatics tools, and data analysis methods continue to shape the competitive landscape and contribute to the growth of the market. For example, in 2023, Thermo Fisher Scientific announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T-cells and B-cells, which play a key role in the immune response system.

Recent Developments:

Pfizer Inc. and Adaptive Biotechnologies Corporation have entered into a translational research collaboration to leverage next-generation sequencing of the adaptive immune system to advance Pfizer's growing immuno-oncology franchise. Under the terms of the agreement, Pfizer and Adaptive will seek to combine drug development and platform technology biomarker expertise to identify patients who may preferentially benefit from immunotherapy.

Key features of the study:

  • This proposed research study on Immune Repertoire Sequencing market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Immune Repertoire Sequencing market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Immune Repertoire Sequencing market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Immune Repertoire Sequencing market
  • Impact of COVID-19 on Immune Repertoire Sequencing market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Immune Repertoire Sequencing market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Immune Repertoire Sequencing market, we have also included competitive landscape and key innovator analysis for the Immune Repertoire Sequencing market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Immune Repertoire Sequencing market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Immune Repertoire Sequencing market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET KEY PLAYERS

  • Illumina Inc.
  • Thermo Fisher Scientific
  • PacBio
  • CD Genomics
  • Agilent Technologies, Inc
  • F. Hoffmann-La Roche Ltd
  • BGI Group Guangdong
  • Takara Bio, Inc.
  • Adaptive Biotechnologies
  • Juno Therapeutics
  • Atreca, Inc.
  • irepertoire, Inc.

GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY PRODUCT TYPE

  • Instruments
  • Assay Kits

GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY APPLICATION

  • Cancer Immunotherapy
  • Biomarker Discovery
  • Autoimmune Diseases
  • Vaccine Development and Efficacy
  • Transplant Rejection and Tolerance
  • Infectious Diseases
  • Others

GLOBAL IMMUNE REPERTOIRE SEQUENCING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

TABLE OF CONTENT

1. Immune Repertoire Sequencing Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Immune Repertoire Sequencing Market Snippet by Product Type
    • 2.1.2. Immune Repertoire Sequencing Market Snippet by Application
    • 2.1.3. Immune Repertoire Sequencing Market Snippet by Country
    • 2.1.4. Immune Repertoire Sequencing Market Snippet by Region
  • 2.2. Competitive Insights

3. Immune Repertoire Sequencing Key Market Trends

  • 3.1. Immune Repertoire Sequencing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Immune Repertoire Sequencing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Immune Repertoire Sequencing Market Opportunities
  • 3.4. Immune Repertoire Sequencing Market Future Trends

4. Immune Repertoire Sequencing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Immune Repertoire Sequencing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Immune Repertoire Sequencing Market Landscape

  • 6.1. Immune Repertoire Sequencing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Immune Repertoire Sequencing Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Instruments
    • 7.1.3. Assay Kits

8. Immune Repertoire Sequencing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Cancer Immunotherapy
    • 8.1.3. Biomarker Discovery
    • 8.1.4. Autoimmune Diseases
    • 8.1.5. Vaccine Development and Efficacy
    • 8.1.6. Transplant Rejection and Tolerance
    • 8.1.7. Infectious Diseases
    • 8.1.8. Others

9. Immune Repertoire Sequencing Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Immune Repertoire Sequencing Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Immune Repertoire Sequencing Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Immune Repertoire Sequencing Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Immune Repertoire Sequencing Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Immune Repertoire Sequencing Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Immune Repertoire Sequencing Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Illumina Inc.
    • 10.2.2. Thermo Fisher Scientific
    • 10.2.3. PacBio
    • 10.2.4. CD Genomics
    • 10.2.5. Agilent Technologies, Inc
    • 10.2.6. F. Hoffmann-La Roche Ltd
    • 10.2.7. BGI Group Guangdong
    • 10.2.8. Takara Bio, Inc.
    • 10.2.9. Adaptive Biotechnologies
    • 10.2.10. Juno Therapeutics
    • 10.2.11. Atreca, Inc.
    • 10.2.12. irepertoire, Inc.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Immune Repertoire Sequencing Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Immune Repertoire Sequencing Market, by Product Type 2018-2030 (USD Million)
  • TABLE Immune Repertoire Sequencing Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Immune Repertoire Sequencing Market, by Application 2018-2030 (USD Million)
  • TABLE Immune Repertoire Sequencing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Immune Repertoire Sequencing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Immune Repertoire Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Immune Repertoire Sequencing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Immune Repertoire Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Immune Repertoire Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Immune Repertoire Sequencing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Immune Repertoire Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Immune Repertoire Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Immune Repertoire Sequencing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Immune Repertoire Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Immune Repertoire Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Immune Repertoire Sequencing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Immune Repertoire Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Immune Repertoire Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Immune Repertoire Sequencing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Immune Repertoire Sequencing Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Immune Repertoire Sequencing Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Technology segment market share analysis, 2022 & 2030
  • FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Immune Repertoire Sequencing Market share and leading players, 2022
  • FIGURE Europe Immune Repertoire Sequencing Market share and leading players, 2022
  • FIGURE Asia Pacific Immune Repertoire Sequencing Market share and leading players, 2022
  • FIGURE Latin America Immune Repertoire Sequencing Market share and leading players, 2022
  • FIGURE Middle East and Africa Immune Repertoire Sequencing Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Immune Repertoire Sequencing Market share analysis by country, 2022
  • FIGURE Germany Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Immune Repertoire Sequencing Market share analysis by country, 2022
  • FIGURE India Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Immune Repertoire Sequencing Market share analysis by country, 2022
  • FIGURE Brazil Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Immune Repertoire Sequencing Market share analysis by country, 2022
  • FIGURE Saudi Arabia Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Immune Repertoire Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)